NEUROVALENS
Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research and development activities aimed at improving the competitiveness of the business.
NEUROVALENS
Industry:
Biotechnology Health Care Life Science
Founded:
2013-01-01
Address:
Belfast, Belfast, United Kingdom
Country:
United Kingdom
Website Url:
http://www.neurovalens.com
Total Employee:
1+
Status:
Active
Total Funding:
17.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Global Site Tag Mobile Non Scaleable Content
Similar Organizations
FC Tecnics
FCTecnics provides solutions within the fields of biotechnology, bioengineering, and microalgae.
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - Neurovalens
Invest Northern Ireland
Invest Northern Ireland investment in Grant - Neurovalens
Future Fund
Future Fund investment in Venture Round - Neurovalens
Clarendon Fund Managers
Clarendon Fund Managers investment in Venture Round - Neurovalens
IQ Capital
IQ Capital investment in Venture Round - Neurovalens
ACF Investors
ACF Investors investment in Venture Round - Neurovalens
Wharton Asset Management Company Limited
Wharton Asset Management Company Limited investment in Venture Round - Neurovalens
Techstart Ventures
Techstart Ventures investment in Venture Round - Neurovalens
Growth Finance Fund
Growth Finance Fund investment in Venture Round - Neurovalens
ACF Investors
ACF Investors investment in Series A - Neurovalens
Official Site Inspections
http://www.neurovalens.com Semrush global rank: 9.51 M Semrush visits lastest month: 144
- Host name: 104.26.10.56
- IP address: 104.26.10.56
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Neurovalens"
Neurovalens
Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world’s greatest health challenges.See details»
Neurostimulation Therapy for Anxiety & Sleep Disorders
Neurovalens uses neurostimulation therapy to address chronic insomnia and anxiety non-invasively. Find out how this health-tech company leads in innovation.See details»
Neurovalens - Crunchbase Company Profile & Funding
Neurovalens received FDA clearance for its noninvasive anxiety treatment. The company also secured US approval and successfully closed a £2.1 million funding round for its wearable anxiety treatment. View contacts for …See details»
Neurovalens Company Profile 2024: Valuation, Funding
Developer of non-invasive neurostimulation products designed to treat global health epidemics.See details»
Trouble Sleeping? FDA Clears Medical Device to Treat …
Oct 31, 2023 · Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat chronic insomnia with its Modius Sleep device.See details»
Neurovalens Company Profile - MedTech Innovator
Neurovalens is a UK medical device company making groundbreaking neurostimulation technology that offers clinically proven, non-invasive solutions to some of the world’s most …See details»
Neurovalens - LinkedIn
Based in Belfast, Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world's greatest health challenges! Modius is the first...See details»
Neurotech startup Neurovalens gets FDA clearance for …
Apr 8, 2024 · A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Belfast-based …See details»
Neurovalens - VentureRadar
Website: http://neurovalens.com/ Develops neuroscience-based health technologies, including a wearable device using electronic brain stimulation to treat anxiety, certified by US health …See details»
Neurovalens - UCSF Rosenman Institute
Dec 15, 2023 · Neurovalens makes non-invasive technology that treats type 2 diabetes by stimulating the area of the brainstem that regulates glucose. Phase III trials are scheduled to …See details»
Neurovalens: A novel, non-invasive solution to …
Apr 15, 2024 · “Neurovalens [has] developed a non-invasive technique that allows stimulation of the deep parts of the brain,” explains McKeown, who is CEO of the company and a visiting scholar at the University...See details»
Belfast’s Neurovalens achieves FDA clearance for insomnia …
Oct 31, 2023 · Neurovalens, a Belfast-based company that specialises in non-invasive neuroscience-influenced medical devices, has received approval from the US Food and Drug …See details»
Neurovalens - Funding, Financials, Valuation & Investors
Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiologySee details»
Neurovalens Receives FDA Clearance for Anxiety Treatment Device
Jul 16, 2024 · Earlier this year, Neurovalens announced the 2022 Rosenman Innovator has received medical device clearance from the FDA to treat anxiety with its Modius Stress device. …See details»
Neurovalens launches Modius Sleep for chronic insomnia - aasm.org
On Oct. 28, 2024, Neurovalens announced it launched its first product, Modius Sleep, an FDA-cleared, physician-prescribed medical device intended to treat chronic insomnia in adults. …See details»
Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device …
Nov 12, 2019 · Neurovalens, a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today introduces Modius SLEESee details»
Conditions of Sale - Neurovalens
These terms and conditions (these “Terms”) apply to the purchase and sale of products through http://104.236.24.27/ (the “Site”). Once an order for products is accepted by Neurovalens, …See details»
Jason McKeown - UCSF Rosenman Institute
Dr Jason McKeown is CEO of Neurovalens, a medical device company with a focus on using electrical stimulation of the brainstem to treat both neurological and metabolic diseases. Jason …See details»
Neurovalens gets FDA nod for neurostimulator to treat anxiety
Apr 23, 2024 · Neurovalens Ltd recently received U.S. FDA clearance for its Modius Stress device, a neurostimulator that treats people suffering from generalized anxiety disorder (GAD). …See details»
“5 Things I Wish Someone Told Me Before I Became CEO of …
Mar 26, 2020 · Upon his completion of the program, Neurovalens was awarded Company of the Year 2015. Thank you for joining us! Can you tell us the story about what brought you to this …See details»